List of Tables
Table 1. Global Factor Xa Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Factor Xa Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Factor Xa Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Factor Xa Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Factor Xa Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Factor Xa Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Factor Xa Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Factor Xa Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Factor Xa Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Factor Xa Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Factor Xa Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Factor Xa Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Factor Xa Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Factor Xa Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Factor Xa Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Factor Xa Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Factor Xa Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Factor Xa Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Factor Xa Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Factor Xa Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Factor Xa Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Factor Xa Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Factor Xa Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Factor Xa Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Factor Xa Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Factor Xa Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Factor Xa Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Factor Xa Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Factor Xa Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Factor Xa Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Factor Xa Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Factor Xa Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Factor Xa Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Factor Xa Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Factor Xa Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Factor Xa Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Factor Xa Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Factor Xa Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Factor Xa Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Factor Xa Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Factor Xa Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Factor Xa Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Factor Xa Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Factor Xa Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Factor Xa Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Factor Xa Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Factor Xa Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Factor Xa Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Factor Xa Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bristol Myers Squibb Factor Xa Inhibitors Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Daiichi Sankyo Company Information
Table 81. Daiichi Sankyo Description and Business Overview
Table 82. Daiichi Sankyo Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Daiichi Sankyo Factor Xa Inhibitors Product
Table 84. Daiichi Sankyo Recent Developments/Updates
Table 85. Janssen Pharmaceuticals Company Information
Table 86. Janssen Pharmaceuticals Description and Business Overview
Table 87. Janssen Pharmaceuticals Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Janssen Pharmaceuticals Factor Xa Inhibitors Product
Table 89. Janssen Pharmaceuticals Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Bayer Factor Xa Inhibitors Product
Table 94. Bayer Recent Developments/Updates
Table 95. Viatris Company Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Viatris Factor Xa Inhibitors Product
Table 99. Viatris Recent Developments/Updates
Table 100. Dr. Reddy's Laboratories Company Information
Table 101. Dr. Reddy's Laboratories Description and Business Overview
Table 102. Dr. Reddy's Laboratories Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Dr. Reddy's Laboratories Factor Xa Inhibitors Product
Table 104. Dr. Reddy's Laboratories Recent Developments/Updates
Table 105. GlaxoSmithKline Company Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. GlaxoSmithKline Factor Xa Inhibitors Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Eugia Pharma Company Information
Table 111. Eugia Pharma Description and Business Overview
Table 112. Eugia Pharma Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Eugia Pharma Factor Xa Inhibitors Product
Table 114. Eugia Pharma Recent Developments/Updates
Table 115. Accord Healthcare Company Information
Table 116. Accord Healthcare Description and Business Overview
Table 117. Accord Healthcare Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Accord Healthcare Factor Xa Inhibitors Product
Table 119. Accord Healthcare Recent Developments/Updates
Table 120. Apotex Company Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Apotex Factor Xa Inhibitors Product
Table 124. Apotex Recent Developments/Updates
Table 125. Zydus Company Information
Table 126. Zydus Description and Business Overview
Table 127. Zydus Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Zydus Factor Xa Inhibitors Product
Table 129. Zydus Recent Developments/Updates
Table 130. Lupin Company Information
Table 131. Lupin Description and Business Overview
Table 132. Lupin Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lupin Factor Xa Inhibitors Product
Table 134. Lupin Recent Developments/Updates
Table 135. Jiangsu Hengrui Pharmaceuticals Company Information
Table 136. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 137. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Product
Table 139. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 140. Cspc Ouyi Pharmaceutical Company Information
Table 141. Cspc Ouyi Pharmaceutical Description and Business Overview
Table 142. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Product
Table 144. Cspc Ouyi Pharmaceutical Recent Developments/Updates
Table 145. Zhejiang Hisun Pharmaceutical Company Information
Table 146. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 147. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Product
Table 149. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 150. Hansoh Pharma Company Information
Table 151. Hansoh Pharma Description and Business Overview
Table 152. Hansoh Pharma Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Hansoh Pharma Factor Xa Inhibitors Product
Table 154. Hansoh Pharma Recent Developments/Updates
Table 155. Chia Tai Tianqing Pharmaceutical Company Information
Table 156. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 157. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Product
Table 159. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 160. Shanghai Huilun Pharmaceutical Company Information
Table 161. Shanghai Huilun Pharmaceutical Description and Business Overview
Table 162. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Product
Table 164. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 165. Qilu Pharmaceutical Company Information
Table 166. Qilu Pharmaceutical Description and Business Overview
Table 167. Qilu Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Qilu Pharmaceutical Factor Xa Inhibitors Product
Table 169. Qilu Pharmaceutical Recent Developments/Updates
Table 170. HEC Pharma Company Information
Table 171. HEC Pharma Description and Business Overview
Table 172. HEC Pharma Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. HEC Pharma Factor Xa Inhibitors Product
Table 174. HEC Pharma Recent Developments/Updates
Table 175. BrightGene Company Information
Table 176. BrightGene Description and Business Overview
Table 177. BrightGene Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. BrightGene Factor Xa Inhibitors Product
Table 179. BrightGene Recent Developments/Updates
Table 180. Kelun Pharmaceutical Company Information
Table 181. Kelun Pharmaceutical Description and Business Overview
Table 182. Kelun Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Kelun Pharmaceutical Factor Xa Inhibitors Product
Table 184. Kelun Pharmaceutical Recent Developments/Updates
Table 185. Nanjing King-Friend Biochemical Pharmaceutical Company Information
Table 186. Nanjing King-Friend Biochemical Pharmaceutical Description and Business Overview
Table 187. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Product
Table 189. Nanjing King-Friend Biochemical Pharmaceutical Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Factor Xa Inhibitors Distributors List
Table 193. Factor Xa Inhibitors Customers List
Table 194. Factor Xa Inhibitors Market Trends
Table 195. Factor Xa Inhibitors Market Drivers
Table 196. Factor Xa Inhibitors Market Challenges
Table 197. Factor Xa Inhibitors Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Factor Xa Inhibitors
Figure 2. Global Factor Xa Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Factor Xa Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Oral Drugs Product Picture
Figure 5. Injections Product Picture
Figure 6. Global Factor Xa Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Factor Xa Inhibitors Market Share by Application: 2025 & 2032
Figure 8. Deep Vein Thrombosis
Figure 9. Pulmonary Embolism
Figure 10. Atrial Fibrillation
Figure 11. Other
Figure 12. Global Factor Xa Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Factor Xa Inhibitors Market Size (US$ Million), 2021–2032
Figure 14. Global Factor Xa Inhibitors Sales (K Units), 2021–2032
Figure 15. Global Factor Xa Inhibitors Average Price (US$/Unit), 2021–2032
Figure 16. Factor Xa Inhibitors Report Years Considered
Figure 17. Factor Xa Inhibitors Sales Share by Manufacturers in 2025
Figure 18. Global Factor Xa Inhibitors Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Factor Xa Inhibitors Players: Market Share by Revenue in Factor Xa Inhibitors in 2025
Figure 20. Factor Xa Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Factor Xa Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 23. North America Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 24. United States Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 27. Europe Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 28. Germany Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Factor Xa Inhibitors Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Factor Xa Inhibitors Revenue Market Share by Region (2021–2032)
Figure 35. China Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 43. Latin America Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Factor Xa Inhibitors by Type (2021–2032)
Figure 54. Global Revenue Market Share of Factor Xa Inhibitors by Type (2021–2032)
Figure 55. Global Factor Xa Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Factor Xa Inhibitors by Application (2021–2032)
Figure 57. Global Revenue Market Share of Factor Xa Inhibitors by Application (2021–2032)
Figure 58. Global Factor Xa Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 59. Factor Xa Inhibitors Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
